Listed

Vericel Corp: Form 10-Q for the period ended Mar 31, 2014

Filed with the SEC on May 15, 2014 and accepted by EDGAR at May 15, 2014, 16:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2014-01-01 to 2014-03-31$3.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2014-01-01 to 2014-03-31$1.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-01-01 to 2014-03-31−$4.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-01-01 to 2014-03-31$2.0kus-gaap:InterestExpense
Net income3 months2014-01-01 to 2014-03-31−$6.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-01-01 to 2014-03-31−$1.26us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2014-01-01 to 2014-03-31−$4.7mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2014-03-31$8.8mus-gaap:Cash
Current assetsAt period end2014-03-31$9.2mus-gaap:AssetsCurrent
Total assetsAt period end2014-03-31$9.9mus-gaap:Assets
Current liabilitiesAt period end2014-03-31$6.1mus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2014-03-31$2.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2014-03-31$3.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-14-039355. Last ingested by Listed: Nov 14, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.